We are excited to announce the addition of the MiSight 1-Day contact lens, the first and only soft contact lens that is FDA-approved to slow the progression of myopia in children, to our comprehensive myopia management options at Grand Eye Care.
Myopia, also known as nearsightedness, is a condition in which the eye does not properly focus light clearly on the retina. As a result, distant images become blurry while near images may remain clear. Low amounts of myopia can be corrected with glasses, contact lenses, and refractive surgery, however, higher amounts of myopia may be more difficult to fully correct. As the amount of myopia increases, the risk of sight-threating eye disorders such as myopic macular degeneration, glaucoma, cataracts, and retinal defects such as holes, tears, and detachments also increase. The goal of MiSight Contact Lens Therapy is to slow myopia progression to prevent the development of these sight-threatening conditions.
The MiSight 1 day contact lens is designed with two treatment zones and two vision correcting zones. Regular contact lenses only have one zone that corrects for nearsightedness, and they unfortunately do not offer any treatment benefit for slowing myopia. The design of the MiSight 1-day contact lens allows for the child to see clearly far away and up close while benefiting from the treatment effect of slowing the progression of myopia.
The Misight 1-day contact lens has been clinically studied and proven to effectively slow the progression of myopia by 59% and slow the rate at which the eye becomes longer by 52% when compared to children wearing a regular, single vision 1-day contact lens.
If you have concerns that your child is developing myopia, or is becoming more myopic each year, then call our office to schedule a consultation with our doctors at Grand Eye Care to see if your child qualifies for MiSight Contact Lens Therapy.
Schedule Consultation